Biblioteca Humberto Rosselli Quijano
Información del autor
Autor Mathias Riesbeck |
Documentos disponibles escritos por este autor (1)
Refinar búsqueda
Relapse prevention in first-episode schizophrenia--maintenance vs intermittent drug treatment with prodrome based early intervention / Wolfgang Gäebel en The Journal of Clinical Psychiatry, Año 2011 - Vol.72 - No.2 (Febrero)
[artículo]
Título : Relapse prevention in first-episode schizophrenia--maintenance vs intermittent drug treatment with prodrome based early intervention : results of a randomized controlled trial within the German Research Network on Schizophrenia Tipo de documento: texto impreso Autores: Wolfgang Gäebel, Autor ; Mathias Riesbeck, Autor ; Wolfgang Wölwer, Autor Fecha de publicación: 2022 Artículo en la página: pp. 205-218 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antipsicótico, Haloperidol, Risperidona, Esquizofrenia, Trastorno esquizotípico de la personalidad. Resumen: After acute treatment of the first illness episode in schizophrenia, antipsychotic maintenance treatment is recommended for at least 1 year. Evidence for the optimal subsequent treatment is still scarce. Link: ./index.php?lvl=notice_display&id=27944
in The Journal of Clinical Psychiatry > Año 2011 - Vol.72 - No.2 (Febrero) . - pp. 205-218[artículo] Relapse prevention in first-episode schizophrenia--maintenance vs intermittent drug treatment with prodrome based early intervention : results of a randomized controlled trial within the German Research Network on Schizophrenia [texto impreso] / Wolfgang Gäebel, Autor ; Mathias Riesbeck, Autor ; Wolfgang Wölwer, Autor . - 2022 . - pp. 205-218.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in The Journal of Clinical Psychiatry > Año 2011 - Vol.72 - No.2 (Febrero) . - pp. 205-218
Palabras clave: Antipsicótico, Haloperidol, Risperidona, Esquizofrenia, Trastorno esquizotípico de la personalidad. Resumen: After acute treatment of the first illness episode in schizophrenia, antipsychotic maintenance treatment is recommended for at least 1 year. Evidence for the optimal subsequent treatment is still scarce. Link: ./index.php?lvl=notice_display&id=27944